With the Summer Meeting of the American Academy of Dermatology (AAD) underway, the Editorial Boards of Cutis and Cosmetic Dermatology have identified sessions that may be of interest to you among others.
To further your education on these important topics in dermatology, select articles in our journal archives will have open access during the AAD meeting.
For studies, review articles, physician columns, and case reports that present the practical side of clinical and appearance-related dermatology to improve patient care, continue to look to original content in Cutis and Cosmetic Dermatology.
Come visit us at booth 903 in the exhibit hall.
For more news from the AAD meeting, go to www.cutis.com or www.cosderm.com.
TODAY’S TOP PICKS
8:00 AM to 9:30 AM
Patch Test Allergens 101: A Detective’s Toolkit
Christen M. Mowad, MD (Cutis Editorial Board)
Putting the Power of Phototherapy to Work for Patients and Providers
Iltefat H. Hamzavi, MD
9:00 AM to 12:00 PM
What’s Breaking Out: Acne and Rosacea
Jonette Elizabeth Keri, MD, PhD; Hilary E. Baldwin, MD; James Q. Del Rosso, DO (Cutis and Cosmetic Dermatology Editorial Boards); Jeremy Green, MD; Terrence Keaney, MD; Heather Clare Woolery-Lloyd, MD; Joshua Zeichner, MD
10:00 AM to 12:00 PM
Phoebe Rich, MD (Cutis Editorial Board); Molly A. Hinshaw, MD; Nathaniel J. Jellinek, MD; Jill M. Moore, MD; Richard K. Scher, MD (Cutis Editorial Board)
Face to Face: Management of Facial Dermatoses
Amber R. Atwater, MD; Nicole Fett, MD; Roopal Vashi Kundu, MD; Sarah A. Wolfe, MD
Meeting room locations are subject to change.
Enjoy open access during the AAD meeting to these recently published Cutis and Cosmetic Dermatology articles.
A Multicenter, Double-blind Study to Evaluate the Efficacy and Safety of 2 Treatments in Participants With Mild to Moderate Acne Vulgaris
Acne treatment regimens have changed due to the recent over-the-counter (OTC) switch of all prescription benzoyl peroxide (BPO) topical preparations. The elimination of prescription single-agent BPO products means that dermatologists must select from a variety of OTC formulations to utilize the time-tested efficacy of BPO in the treatment of mild to moderate acne. This study compared the efficacy and safety of an OTC BPO 5.5% formulation with lipohydroxy acid and tretinoin cream 0.025% with prescription clindamycin 1%–BPO 5% gel and tretinoin cream 0.025%.
Nails are an integral part of any complete dermatologic and/or physical/medical examination. There are many different aspects of nail care, and it is the dermatologist's responsibility to make patients aware of adverse effects and industry abuses that could arise in this huge arena.
Skin Care Based on Science: Improving Outcomes in Rosacea
Patients with rosacea have compromised skin barrier function and are more prone to dryness, irritation, and skin sensitivity. With an understanding of the pathogenesis and inherent skin problems that rosacea patients experience, it is essential for dermatologists to provide specific recommendations for skin care. This article reviews topical skin care products that may improve treatment outcomes in rosacea patients.